YC W26
Strand AI
Multimodal foundation models to predict uncollected patient biology
About
Strand AI develops foundation models to generate missing bio-data about patients. With this imputed data, pharmaceutical companies can select better patients for their drug trials and shave months from their drug launch timelines. We’ve already trained a multimodal foundation model that integrates spatial biology modalities, beating SOTA at a fraction of the cost.
Founders
- Yue Dai
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Strand AI.
See family office activityIndustry & Focus
HealthcareDrug Discovery and Delivery